CONNECT: Smoking Cessation and Lung Cancer Screening

University of California San Francisco (UCSF)

Status: Completed

Conditions: Smoking Cessation

Treatments: Other: Computer-Assisted Intervention no Video Doctor; Other: Computer-Assisted Intervention Video Doctor

Study type: Interventional

Funder types: Other; Other U.S. Federal agency

Identifiers

NCT04149249

NCI-2018-03884 (Registry Identifier)

18-25632

186515 (Other Identifier)

Details and patient eligibility

About

This clinical trial studies the impact of CONNECT on biochemically confirmed smoking abstinence among diverse current smokers who are undergoing lung cancer screening.

Full description

The study team will develop and test a novel smoking cessation intervention, CONNECT, which will start at the time an individual is receiving lung cancer screening (LCS). CONNECT will include an interactive Video Doctor which will provide participants with information tailored to their individual responses as well as proactive outreach using brief telephone calls and text messaging to follow up smokers with motivation enhancement to refer and engage patients in evidence based smoking cessation interventions (such as quitline utilization). After development and usability testing, we will conduct a small feasibility study followed by a pilot randomized controlled trial to estimate the impact of CONNECT on biochemically confirmed 30-day smoking abstinence among diverse current smokers seen at the San Francisco Veterans Affairs Medical Center and the University of California San Francisco Division of General Internal Medicine. Participants will be randomized to CONNECT or a control condition. Data will include self-report from participants obtained at baseline, 1 and 3 months, and the electronic health record. Outcomes will be biochemically confirmed 30-day smoking abstinence at 3 months post LCS and satisfaction as well as self-reported quit attempts, and use of evidence-based smoking cessation resources (quitline, pharmacotherapy or counseling). The knowledge gained will provide the pilot data necessary to apply for a larger study to test our novel intervention for promoting smoking cessation among a diverse population of high-risk smokers undergoing Lung Cancer Screening.

Enrollment: 99 patients

Sex: All

Ages: 55 to 80 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Age 55-80
• Male or female
• English speaking
• Have an already scheduled low-dose computed tomography (LDCT) visit
• Smoke at least 1 cigarette in the last 7 days
• Have a phone that can receive text messages.

Exclusion criteria

• Younger than 55 or older than 80
• Does not speak English
• Does not have a scheduled low-dose computed tomography (LDCT) visit
• Does not smoke at least 1 cigarette in the last 7 days
• Does not have a phone that can receive text messages.

Trial design

Primary purpose: Other

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

99 participants in 2 patient groups

Experimental: Intervention Group (CONNECT)

Experimental group

Description:

Patients complete CONNECT, the Video Doctor over 30-45 minutes on an iPad in the waiting room before their lung cancer screening test appointment.

Treatment:

Other: Computer-Assisted Intervention Video Doctor

Control Group

Active Comparator group

Description:

Patients complete CONNECT assessment only over 30-45 minutes on an iPad in the waiting room before their lung cancer screening test appointment. Individuals who are randomized to the control group will undergo the same assessment questions and all follow up assessments like the intervention group. Instead of viewing and participating in the interactive Video Doctor about Smoking Cessation, they receive a handout containing smoking cessation resources.

Treatment:

Other: Computer-Assisted Intervention no Video Doctor